Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 99,787 | 44,961 | 34,924 | 39,737 | 70,691 |
| General And Administrative Expense | 98,432 | 43,611 | 33,574 | 37,857 | 69,341 |
| Operating Expense | 99,787 | 44,961 | 34,924 | 97,009 | 70,691 |
| Operating Income | -99,787 | -44,961 | -34,924 | -97,009 | -70,691 |
| EBIT | -99,788 | -44,961 | -34,924 | -89,120 | -6.5M |
| Interest Expense | 1,209 | 887.00 | 994.00 | -31,161 | 2,029 |
| Interest Expense Non Operating | 1,209 | 887.00 | 994.00 | -31,161 | 2,029 |
| Net Interest Income | -1,209 | -887.00 | -994.00 | 31,161 | -2,029 |
| Other Income Expense | -1.00 | -- | -- | 7,889 | -6.4M |
| Special Income Charges | -1.00 | 0.00 | 0.00 | 4,395 | -6.4M |
| Pretax Income | -100,997 | -45,848 | -35,918 | -57,959 | -6.5M |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -100,997 | -45,848 | -35,918 | -57,959 | -6.5M |
| Net Income From Continuing Operation Net Minority Interest | -100,997 | -45,848 | -35,918 | -57,959 | -6.5M |
| Net Income Including Noncontrolling Interests | -100,997 | -45,848 | -35,918 | -57,959 | -6.5M |
| Minority Interests | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Common Stockholders | -100,997 | -45,848 | -35,918 | -57,959 | -6.5M |
| Net Income | -100,997 | -45,848 | -35,918 | -57,959 | -6.5M |
| EBITDA | -99,788 | -44,961 | -34,924 | -89,120 | -6.5M |
| Normalized EBITDA | -99,787 | -44,961 | -34,924 | -93,515 | -70,691 |
| Basic EPS | -0.01 | 0.00 | 0.00 | -- | -0.72 |
| Diluted EPS | -0.01 | 0.00 | 0.00 | -- | -0.72 |
| Basic Average Shares | 13.2M | 10.7M | 10.5M | -- | 9.0M |
| Diluted Average Shares | 13.2M | 10.7M | 10.5M | -- | 9.0M |
| Total Unusual Items | -1.00 | 0.00 | 0.00 | 4,395 | -6.4M |
| Total Unusual Items Excluding Goodwill | -1.00 | 0.00 | 0.00 | 4,395 | -6.4M |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -100,996 | -45,848 | -35,918 | -62,354 | -72,720 |
| Diluted NI Availto Com Stockholders | -100,997 | -45,848 | -35,918 | -57,959 | -6.5M |
| Gain On Sale Of Ppe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Impairment Of Capital Assets | 1.00 | 0.00 | 0.00 | -4,395 | 6.4M |
| Net Income Continuous Operations | -100,997 | -45,848 | -35,918 | -57,959 | -6.5M |
| Net Non Operating Interest Income Expense | -1,209 | -887.00 | -994.00 | 31,161 | -2,029 |
| Other Gand A | 94,304 | 39,483 | 29,446 | 33,029 | 65,231 |
| Rent And Landing Fees | 4,128 | 4,128 | 4,128 | 4,828 | 4,110 |
| Rent Expense Supplemental | 4,128 | 4,128 | 4,128 | 4,828 | 4,110 |
| Salaries And Wages | -- | -- | -- | 0.00 | 0.00 |
| Selling And Marketing Expense | 1,355 | 1,350 | 1,350 | 1,880 | 1,350 |
| Total Expenses | 99,787 | 44,961 | 34,924 | 97,009 | 70,691 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 168,130 | 4,492 | 22,356 | 23,037 | 9,716 |
| Cash Cash Equivalents And Short Term Investments | 168,130 | 4,492 | 22,356 | 23,037 | 9,716 |
| Cash Financial | 168,130 | 4,492 | 22,356 | 23,037 | 9,716 |
| Accounts Receivable | 21,607 | 17,209 | 15,073 | 24,615 | 15,604 |
| Receivables | 21,607 | 17,209 | 15,073 | 24,615 | 15,604 |
| Prepaid Assets | 117,167 | 12,419 | 20,054 | 22,304 | 9,918 |
| Current Assets | 306,904 | 34,120 | 57,483 | 69,956 | 35,238 |
| Net PPE | 95,395 | 2.00 | 2.00 | 2.00 | 2.00 |
| Total Non Current Assets | 95,395 | 2.00 | 2.00 | 2.00 | 2.00 |
| Total Assets | 402,300 | 34,122 | 57,485 | 69,958 | 35,240 |
| Accounts Payable | 80,857 | 58,219 | 18,984 | 22,789 | 63,118 |
| Payables | 80,857 | 58,219 | 18,984 | 22,789 | 63,118 |
| Payables And Accrued Expenses | 110,107 | 78,719 | 66,234 | 62,789 | 66,618 |
| Current Accrued Expenses | 29,250 | 20,500 | 47,250 | 40,000 | 3,500 |
| Other Current Liabilities | -- | -- | -- | -- | 3,494 |
| Current Liabilities | 110,107 | 78,719 | 66,234 | 62,789 | 70,112 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 110,107 | 78,719 | 66,234 | 62,789 | 70,112 |
| Common Stock | 18.7M | 18.2M | 18.2M | 18.2M | 18.1M |
| Capital Stock | 18.7M | 18.2M | 18.2M | 18.2M | 18.1M |
| Retained Earnings | -18.2M | -18.1M | -19.8M | -19.9M | -19.8M |
| Gains Losses Not Affecting Retained Earnings | 0.00 | 0.00 | 1.8M | 1.9M | 1.9M |
| Common Stock Equity | 505,657 | 168,867 | 204,715 | 220,633 | 178,592 |
| Stockholders Equity | 505,657 | 168,867 | 204,715 | 220,633 | 178,592 |
| Total Equity Gross Minority Interest | 292,193 | -44,597 | -8,749 | 7,169 | -34,872 |
| Minority Interest | -213,464 | -213,464 | -213,464 | -213,464 | -213,464 |
| Total Capitalization | 505,657 | 168,867 | 204,715 | 220,633 | 178,592 |
| Net Tangible Assets | 505,657 | 168,867 | 204,715 | 220,633 | 178,592 |
| Tangible Book Value | 505,657 | 168,867 | 204,715 | 220,633 | 178,592 |
| Working Capital | 196,797 | -44,599 | -8,751 | 7,167 | -34,874 |
| Invested Capital | 505,657 | 168,867 | 204,715 | 220,633 | 178,592 |
| Share Issued | 15.2M | 10.7M | 10.6M | 10.4M | 9.0M |
| Ordinary Shares Number | 15.2M | 10.7M | 10.6M | 10.4M | 9.0M |
| Non Current Prepaid Assets | -- | -- | -- | 0.00 | 0.00 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -178,753 | -27,864 | -20,681 | -87,979 | -43,774 |
| Cash Flow From Continuing Operating Activities | -178,753 | -27,864 | -20,681 | -87,979 | -43,774 |
| Stock Based Compensation | -- | -- | -- | 0.00 | 0.00 |
| Change In Working Capital | -77,758 | 17,984 | 15,237 | -22,131 | 28,946 |
| Change In Receivables | -4,398 | -2,136 | 9,542 | -5,916 | 1,842 |
| Change In Payables And Accrued Expense | 31,388 | 12,485 | 3,445 | -3,829 | 17,163 |
| Net PPE Purchase And Sale | 0.00 | 0.00 | 0.00 | -- | 0.00 |
| Purchase Of Business | -- | -- | -- | 0.00 | 0.00 |
| Investing Cash Flow | -95,394 | 0.00 | 0.00 | 1,300 | 0.00 |
| Cash Flow From Continuing Investing Activities | -95,394 | 0.00 | 0.00 | 1,300 | 0.00 |
| Financing Cash Flow | 437,785 | 10,000 | 20,000 | -- | 0.00 |
| Cash Flow From Continuing Financing Activities | 437,785 | 10,000 | 20,000 | -- | 0.00 |
| Changes In Cash | 163,638 | -17,864 | -681.00 | 13,321 | -43,774 |
| Beginning Cash Position | 4,492 | 22,356 | 23,037 | 9,716 | 53,490 |
| End Cash Position | 168,130 | 4,492 | 22,356 | 23,037 | 9,716 |
| Free Cash Flow | -274,147 | -27,864 | -20,681 | -87,979 | -43,774 |
| Interest Paid Supplemental Data | -- | -- | 994.00 | -- | -- |
| Asset Impairment Charge | 1.00 | 0.00 | 0.00 | -4,395 | 6.4M |
| Change In Prepaid Assets | -104,748 | 7,635 | 2,250 | -12,386 | 9,941 |
| Gain Loss On Sale Of PPE | 0.00 | 0.00 | 0.00 | -- | 0.00 |
| Net Business Purchase And Sale | -- | -- | -- | 0.00 | 0.00 |
| Net Income From Continuing Operations | -100,996 | -45,848 | -35,918 | -57,959 | -6.5M |
| Net Other Investing Changes | -- | -- | -- | -- | -- |
| Operating Gains Losses | -- | -- | -- | 0.00 | 0.00 |
| Proceeds From Stock Option Exercised | 41,785 | 10,000 | 20,000 | -- | 0.00 |
| Sale Of PPE | 0.00 | 0.00 | 0.00 | -- | 0.00 |